Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5776433 | MYLAN SPECIALITY LP | Flunisolide aerosol formulations |
Jul, 2015
(8 years ago) | |
US5980867 | MYLAN SPECIALITY LP | Flunisolide aerosol formulations |
Jul, 2018
(5 years ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
M(M-128) | Aug 28, 2016 |
Market Authorisation Date: 27 January, 2006
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION